Newly Developed Hypervascular Hepatocellular Carcinoma During Follow-Up Periods in Patients With Chronic Liver Disease: Observation in Serial Gadoxetic Acid–Enhanced MRI
- 1 June 2013
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 200 (6) , 1254-1260
Abstract
OBJECTIVE. The purpose of our study was to evaluate the process and frequency of newly developed hypervascular hepatocellular carcinoma (HCC) in serial gadoxetic acid–enhanced MRI examinations in patients with chronic liver disease during clinical follow-up periods. MATERIALS AND METHODS. After review of 341 MRI examinations in 100 patients with chronic liver diseases who underwent gadoxetic acid–enhanced MRI at least twice during the observation period, 32 newly developed hypervascular HCCs in 14 patients were retrospectively evaluated. Serial MRI examinations before detecting hypervascular HCC were evaluated to determine whether hypervascular HCC showed the presence of a hypoin-tense nodule on the hepatobiliary phase and hypovascularity (high-risk nodule) before hyper-vascularization. The size of newly developed hypervascular HCCs and the duration of hyper-vascularization from initial detection of a high-risk nodule were compared between HCCs with and without the presence of a high-risk nodule. RESULTS....Keywords
This publication has 16 references indexed in Scilit:
- Evolution of Hypointense Hepatocellular Nodules Observed Only in the Hepatobiliary Phase of Gadoxetate Disodium–Enhanced MRIAmerican Journal of Roentgenology, 2011
- Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver diseaseJournal of Magnetic Resonance Imaging, 2011
- Additional value of gadoxetic acid‐DTPA‐enhanced hepatobiliary phase MR imaging in the diagnosis of early‐stage hepatocellular carcinoma: Comparison with dynamic triple‐phase multidetector CT imagingJournal of Magnetic Resonance Imaging, 2011
- Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging Findings of Borderline Lesions at High Risk for Progression to Hypervascular Classic Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 2011
- Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosisEuropean Radiology, 2011
- Enhancement of liver parenchyma after injection of hepatocyte‐specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumineJournal of Magnetic Resonance Imaging, 2010
- Consensus report of the 2nd International Forum for Liver MRIEuropean Radiology, 2009
- Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.Radiology, 1992
- A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRIMagnetic Resonance in Medicine, 1991
- Multicentric Independent Development of Hepatocellular Carcinoma Revealed by Analysis of Hepatitis B Virus Integration PatternAmerican Journal of Surgical Pathology, 1989